- Home
- BPRN vs ELDN Comparison
BPRN vs ELDN Comparison
Compare BPRN & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPRN
- ELDN
- Stock Information
- Founded
- BPRN 2007
- ELDN 2004
- Country
- BPRN United States
- ELDN United States
- Employees
- BPRN N/A
- ELDN N/A
- Industry
- BPRN Major Banks
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- BPRN Finance
- ELDN Health Care
- Exchange
- BPRN Nasdaq
- ELDN Nasdaq
- Market Cap
- BPRN 216.1M
- ELDN 178.4M
- IPO Year
- BPRN N/A
- ELDN N/A
- Fundamental
- Price
- BPRN $29.45
- ELDN $2.72
- Analyst Decision
- BPRN Strong Buy
- ELDN Strong Buy
- Analyst Count
- BPRN 1
- ELDN 2
- Target Price
- BPRN $35.00
- ELDN $12.50
- AVG Volume (30 Days)
- BPRN 10.2K
- ELDN 205.3K
- Earning Date
- BPRN 07-24-2025
- ELDN 08-18-2025
- Dividend Yield
- BPRN 4.08%
- ELDN N/A
- EPS Growth
- BPRN N/A
- ELDN N/A
- EPS
- BPRN 1.67
- ELDN N/A
- Revenue
- BPRN $73,010,000.00
- ELDN N/A
- Revenue This Year
- BPRN $14.19
- ELDN N/A
- Revenue Next Year
- BPRN $15.48
- ELDN N/A
- P/E Ratio
- BPRN $17.66
- ELDN N/A
- Revenue Growth
- BPRN 6.10
- ELDN N/A
- 52 Week Low
- BPRN $27.25
- ELDN $2.30
- 52 Week High
- BPRN $39.35
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- BPRN 42.02
- ELDN 35.43
- Support Level
- BPRN $30.06
- ELDN $2.76
- Resistance Level
- BPRN $29.75
- ELDN $2.90
- Average True Range (ATR)
- BPRN 0.52
- ELDN 0.16
- MACD
- BPRN -0.15
- ELDN -0.03
- Stochastic Oscillator
- BPRN 18.04
- ELDN 4.39
About BPRN Princeton Bancorp Inc. (PA)
Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.